D-altrofurano-heptulose-3

CAS No. 25545-06-6

D-altrofurano-heptulose-3( alpha-D-Altro-3-heptulofuranose )

Catalog No. M29466 CAS No. 25545-06-6

D-altrofurano-heptulose-3 is isolated from the rhizomes of Actinidia kolomikta (Rupr. & Maxim.) Maxim., Actinidiaceae.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 302 Get Quote
10MG 447 Get Quote
25MG 808 Get Quote
50MG 1226 Get Quote
100MG 1797 Get Quote
200MG 2695 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    D-altrofurano-heptulose-3
  • Note
    Research use only, not for human use.
  • Brief Description
    D-altrofurano-heptulose-3 is isolated from the rhizomes of Actinidia kolomikta (Rupr. & Maxim.) Maxim., Actinidiaceae.
  • Description
    D-altrofurano-heptulose-3 is isolated from the rhizomes of Actinidia kolomikta (Rupr. & Maxim.) Maxim., Actinidiaceae.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    alpha-D-Altro-3-heptulofuranose
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    25545-06-6
  • Formula Weight
    210.18
  • Molecular Formula
    C7H14O7
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    OC[C@H]([C@]([C@@H]1O)(O)O[C@H](CO)[C@H]1O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Glyceryl monostearat...

    Glyceryl monostearate is an agent of emulsifying.

  • Transdermal Peptide ...

    Transdermal Peptide TFA (TD 1 Peptide TFA) is an 11-amino acid polypeptide that binds to Na+/K+ -atpase beta-subunit (ATP1B1) and interacts with the C terminal of ATP1B1.Transdermal Peptide TFA can enhance the transmission of some large molecules in the skin.

  • LY3372689

    LY3372689 (Formulaic Ia) is an orally active O-GlcNAcase (OGA) enzyme inhibitor targeting tau protein-based disorders, including Alzheimer's disease.